HomeCompareBKDV vs MRK

BKDV vs MRK: Dividend Comparison 2026

BKDV yields 0.60% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $36.3K in total portfolio value
10 years
BKDV
BKDV
● Live price
0.60%
Share price
$29.66
Annual div
$0.18
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.5K
Annual income
$62.76
Full BKDV calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — BKDV vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBKDVMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BKDV + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BKDV pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BKDV
Annual income on $10K today (after 15% tax)
$51.30/yr
After 10yr DRIP, annual income (after tax)
$53.35/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $8,275.06/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BKDV + MRK for your $10,000?

BKDV: 50%MRK: 50%
100% MRK50/50100% BKDV
Portfolio after 10yr
$38.6K
Annual income
$4,930.45/yr
Blended yield
12.76%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

BKDV
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BKDV buys
0
MRK buys
0
No recent congressional trades found for BKDV or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBKDVMRK
Forward yield0.60%2.76%
Annual dividend / share$0.18$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$20.5K$56.8K
Annual income after 10y$62.76$9,798.13
Total dividends collected$617.00$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: BKDV vs MRK ($10,000, DRIP)

YearBKDV PortfolioBKDV Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$10,760$60.35$11,206$366.19$446.00MRK
2$11,574$60.69$12,650$502.35$1.1KMRK
3$12,445$61.01$14,407$694.19$2.0KMRK
4$13,378$61.31$16,585$967.82$3.2KMRK
5$14,376$61.59$19,342$1,363.89$5.0KMRK
6$15,444$61.86$22,913$1,947.19$7.5KMRK
7$16,587$62.10$27,662$2,823.89$11.1KMRK
8$17,811$62.34$34,159$4,173.35$16.3KMRK
9$19,120$62.56$43,337$6,308.80$24.2KMRK
10$20,521$62.76$56,776$9,798.13$36.3KMRK

BKDV vs MRK: Complete Analysis 2026

BKDVStock

The fund seeks capital appreciation by investing primarily in value stocks — stocks that are included in at least one of the Russell 3000 Value Index, the S&P Composite 1500 Value Index or the MSCI ACWI Value Index, or a company that has a lower price-to-book ratio than the S&P 500 Index. The fund's managers look to identify companies with attractive valuations, strong fundamentals and catalyst-driven business momentum. The fund can invest in companies of any size, but generally focuses on the stocks of large capitalization companies. Liquid ETF structure allows investors to buy or sell any time the market is open.

Full BKDV Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this BKDV vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BKDV vs SCHDBKDV vs JEPIBKDV vs OBKDV vs KOBKDV vs MAINBKDV vs JNJBKDV vs ABBVBKDV vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.